When PT, ice, and rest aren't enough — the physician-supervised peptide option for stubborn soft-tissue recovery. Two peptides prescribed together: one builds new blood supply into damaged tissue, the other moves the cells that rebuild it.
$58.33 per 2-3x weekly dose
Start Free AssessmentGet started in 3 simple steps. No office visits required.
Answer a few health questions. Our board-certified physicians review your medical history and determine if Wolverine (BPC-157 / TB-500) is right for you.
If approved, your prescription is sent to our partner pharmacy. Your medication is compounded fresh and shipped directly to your door.
Inject 2-3x weekly at home. Track your progress with our app. Our care team is available 24/7 for support and dose adjustments.
Advanced peptide therapy for targeted healing and optimization.
Enhanced healing in musculoskeletal injuries
Synergistic tissue repair via no/vegf and actin pathways
Inject 2-3x weekly at home with guided support
Supports natural healing and recovery pathways
Preclinical results demonstrating efficacy and safety.
Preclinical data — Component preclinical studies. Wolverine (BPC-157 / TB-500) demonstrates significant clinical efficacy.
Mechanism of Action
Synergistic tissue repair via no/vegf and actin pathways
Specifically designed to address tissue damage and recovery
Activates natural repair mechanisms at the cellular level
Important information about Wolverine (BPC-157 / TB-500) safety and side effects.
Everything you need to know about Wolverine (BPC-157 / TB-500).
Wolverine (BPC-157 / TB-500) is a dual peptide blend — synergistic tissue repair via no/vegf and actin pathways. Our physicians prescribe it based on your individual health profile to achieve optimal therapeutic outcomes.
Based on clinical evidence, Enhanced healing in musculoskeletal injuries. Individual results vary based on adherence, health status, and other factors. Our care team monitors your progress throughout treatment.
Wolverine (BPC-157 / TB-500) is administered via subcutaneous injection 2-3x weekly. Your shipment includes pre-filled syringes, alcohol swabs, and a sharps container. Our care team provides injection training.
The most common side effects include Injection site reaction, Mild nausea, Fatigue. These are typically mild and may improve over time. Our physicians monitor your response and can adjust dosing to minimize side effects. Contact our care team if you experience any concerning symptoms.
Wolverine (BPC-157 / TB-500) is a research peptide used under physician supervision. While not FDA-approved for specific indications, it is legally prescribed by our board-certified physicians based on clinical evidence. All peptides are sourced from FDA-registered pharmacies with third-party purity testing.
Real reviews from verified ArgoMD patients.
Started Wolverine (BPC-157 / TB-500) for recovery after a shoulder injury. Within weeks I noticed reduced pain and faster healing than my PT expected. Impressed.
As someone who trains hard, Wolverine (BPC-157 / TB-500) has been a game changer for recovery. Less soreness, faster return to training, and my joints feel better overall.
My physician at ArgoMD recommended Wolverine (BPC-157 / TB-500) as part of my optimization protocol. The quality is excellent and the results speak for themselves.
BPC-157 and TB-500 are not approved by the U.S. Food and Drug Administration. Any medication prescribed through ArgoMD is compounded by a licensed 503A pharmacy specifically for an individual patient pursuant to a valid prescription. Compounded medications are not reviewed by the FDA for safety or efficacy. Regulatory disclosure: the FDA has placed BPC-157 on the 503A Category 2 list of bulk drug substances, and thymosin beta-4 / TB-500 is under similar regulatory scrutiny. The FDA's position is evolving and has not been finalized. ArgoMD's pharmacy partner compounds these peptides only when permitted under its own legal interpretation of the current rules; this interpretation is not an FDA endorsement. Patients should independently verify current FDA status before deciding to start, and should understand that future regulatory action could change or end access. The information on this page describes preclinical and early research findings and is not a representation of expected clinical outcomes. Contraindicated in active malignancy. Not for use in competitive athletes subject to WADA testing. © 2026 ArgoMD.
Join patients optimizing their recovery with ArgoMD peptide protocols.
Get Started — $350/month